Enzosafe Tablet is a combination pharmaceutical formulation containing Bromelain 90mg, Trypsin 48mg, and Rutoside 100mg, designed to provide anti-inflammatory, proteolytic, and vascular protective effects. Bromelain, a proteolytic enzyme derived from pineapple stems, facilitates the breakdown of proteins, thereby aiding in the reduction of inflammation and edema. Trypsin, another proteolytic enzyme, complements Bromelain by enhancing the degradation of inflammatory mediators and promoting tissue repair. Rutoside, a bioflavonoid, exhibits potent antioxidant properties and strengthens capillary walls, reducing capillary permeability and fragility, which is beneficial in managing vascular disorders. The synergistic action of these components makes Enzosafe effective in the treatment of acute and chronic inflammatory conditions, including post-traumatic swelling, sports injuries, and postoperative edema. Additionally, it supports microcirculation and helps alleviate symptoms associated with venous insufficiency. Enzosafe is indicated as an adjunct therapy in inflammatory diseases and conditions requiring proteolytic enzyme supplementation. It should be used under medical supervision, with caution in patients with hypersensitivity to any component or bleeding disorders. The recommended dosage and duration of therapy should be adhered to as per physician guidance to ensure optimal therapeutic outcomes.